查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1956799

伴侶動物健康市場分析及預測（至2035年）：依類型、產品類型、服務、技術、組件、應用、設備、最終用戶、解決方案、模式

Companion Animal Health Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Device, End User, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 374 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到2034年，伴侶動物健康市場規模將從2024年的154億美元成長至312億美元，年複合成長率約為6.6%。該市場涵蓋旨在維護和改善寵物健康的各類產品和服務（例如動物醫藥、診斷試劑和營養補充劑）。寵物主人數量的增加和人們對動物健康的意識提升推動了該市場的強勁成長。獸醫學、個人化醫療和預防保健領域的創新是關鍵促進因素，加上寵物保險和健康管理計畫的擴展，這些因素共同促進了伴侶動物生活品質的提升。

受寵物主人數量不斷成長和動物福利意識提升的推動，伴侶動物健康市場正經歷強勁成長。醫藥領域在該市場中佔據主導地位，這得益於獸醫學的進步和針對慢性疾病的標靶治療的開發。疫苗，尤其是犬貓疫苗，是成長第二快的細分市場，反映了醫療保健干預措施的擴展。診斷領域也取得了顯著成長，院內診斷工具和就地檢驗的重要性日益凸顯。這些創新使得及時、準確的健康評估成為可能，從而提高了獸醫服務的品質。專注於疾病管理和針對不同生命階段營養的營養產品越來越受歡迎，進一步推動了市場成長。此外，遠端醫療服務的興起為遠端諮詢和監測提供了新的機遇，滿足了寵物飼主不斷變化的需求。對研發和策略夥伴關係的投資對於維持市場成長動能和應對伴侶動物領域新出現的健康挑戰至關重要。

市場區隔
類型 疫苗、藥品、飼料添加物、診斷試劑、治療藥物、營養補充品、生物製藥
產品 動物用藥品、寵物食品、動物營養補充品、醫療設備、穿戴式設備
服務 獸醫診所、寵物美容、寵物飯店、寵物訓練、寵物保險
科技 數位健康、遠端醫療、穿戴式科技、基因組學、生物技術、人工智慧
成分 軟體、硬體和服務
應用 疾病治療、預防醫學、營養管理、康復
裝置 監測、治療和診斷設備
最終用戶 獸醫診所、居家照護機構和研究機構
解決方案 臨床、營運和財務解決方案
模式 現場診療、遠距監測和遠端醫療

伴侶動物健康市場正經歷市場佔有率、定價策略和產品創新方面的動態變化。主要企業正策略性地推出新產品，以滿足日益成長的先進動物保健解決方案的需求。該市場的特點是產品種類繁多，涵蓋從預防保健到複雜治療的各種健康需求。定價策略也不斷演變，以應對競爭壓力和消費者期望，重點在於透過提高療效和客戶滿意度來創造價值。在競爭標竿方面，主要參與者正透過創新和策略聯盟不斷實現差異化。監管影響至關重要，嚴格的指導方針塑造產品開發和打入市場策略。對動物福利的日益重視以及通用感染疾病的增加也對市場產生影響。競爭格局的特點是跨國公司和新興區域企業並存，它們正競相透過技術創新和拓展分銷網路來鞏固自身地位。

主要趨勢和促進因素：

受寵物飼養率上升和動物福利意識增強的推動，伴侶動物健康市場正經歷強勁成長。一個顯著的趨勢是，對先進獸醫診斷和治療方法的需求激增，這反映出人們對預防保健和疾病早期發現的重視。遠端照護和穿戴式寵物健康監測設備等技術創新正在透過帶來便利和改善健康結果來改變市場格局。另一個關鍵促進因素是寵物的人性化。飼主願意投資高級產品和服務，這推動了寵物營養和個人化醫療等領域的創新。獸醫診所和寵物醫療保健基礎設施的擴張，尤其是在新興市場，也促進了市場成長。此外，產業參與者之間的策略聯盟和合作正在促進新解決方案的開發和市場擴張。尤其是在獸醫服務資源有限的地區，開發經濟高效的治療方法和診斷工具存在著巨大的機會。專注於研發解決伴侶動物特定健康問題的公司，將能更好地掌握這些趨勢帶來的機會。對永續和環保產品的重視與消費者對環保選擇的廣泛偏好相一致，進一步塑造了市場。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 疫苗
    • 製藥
    • 飼料添加劑
    • 診斷試劑
    • 治療藥物
    • 營養保健品
    • 生物製藥
  • 市場規模及預測：依產品分類
    • 動物用藥品
    • 寵物食品
    • 動物補充品
    • 醫療設備
    • 穿戴式裝置
  • 市場規模及預測：依服務分類
    • 獸醫診所
    • 寵物美容
    • 寵物寄宿服務
    • 寵物訓練
    • 寵物保險
  • 市場規模及預測：依技術分類
    • 數位健康
    • 遠端醫療
    • 穿戴式科技
    • 基因組學
    • 生物技術
    • 人工智慧
  • 市場規模及預測：依組件分類
    • 軟體
    • 硬體
    • 服務
  • 市場規模及預測：依應用領域分類
    • 疾病治療
    • 預防醫學
    • 營養管理
    • 復原
  • 市場規模及預測：依設備分類
    • 監測設備
    • 治療設備
    • 診斷設備
  • 市場規模及預測：依最終用戶分類
    • 獸醫診所
    • 居家照護環境
    • 研究所
  • 市場規模及預測：按解決方案分類
    • 臨床解決方案
    • 營運解決方案
    • 金融解決方案
  • 市場規模及預測：按模式
    • 面對面
    • 遠端監控
    • 遠端醫療

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Vetoquinol
  • Dechra Pharmaceuticals
  • Virbac
  • Heska Corporation
  • Zoetis
  • Elanco Animal Health
  • Boehringer Ingelheim Animal Health
  • Ceva Sante Animale
  • Phibro Animal Health
  • IDEXX Laboratories
  • Merck Animal Health
  • Bimeda
  • Neogen Corporation
  • Kyoritsu Seiyaku
  • Ourofino Saude Animal
  • Bio Chek
  • Vetcare
  • Norbrook Laboratories
  • Hipra
  • Eco Animal Health

第9章：關於我們

簡介目錄
Product Code: GIS21322

Companion Animal Health Market is anticipated to expand from $15.4 billion in 2024 to $31.2 billion by 2034, growing at a CAGR of approximately 6.6%. The Companion Animal Health Market encompasses products and services aimed at maintaining and improving the health of pets, including veterinary pharmaceuticals, diagnostics, and nutritional supplements. With rising pet ownership and increasing awareness of animal health, this market is experiencing robust growth. Innovations in veterinary care, personalized medicine, and preventive healthcare are key drivers, alongside the expansion of pet insurance and wellness programs, enhancing the quality of life for companion animals.

The Companion Animal Health Market is experiencing robust growth, propelled by rising pet ownership and increasing awareness of animal welfare. Within this market, the pharmaceuticals segment leads, driven by advancements in veterinary medicine and the development of targeted treatments for chronic conditions. Vaccines, particularly for canine and feline species, represent the second highest performing sub-segment, reflecting growing preventive healthcare measures. The diagnostics segment is also witnessing significant expansion, with in-clinic diagnostic tools and point-of-care testing gaining prominence. These innovations enable timely and accurate health assessments, enhancing veterinary care. Nutritional products, focusing on specialized diets for disease management and life stage-specific nutrition, are increasingly popular, further supporting market growth. Additionally, the rise of telemedicine services offers new opportunities for remote consultations and monitoring, catering to the evolving needs of pet owners. Investment in research and development, alongside strategic partnerships, is crucial for sustaining market momentum and addressing emerging health challenges in companion animals.

Market Segmentation
TypeVaccines, Pharmaceuticals, Feed Additives, Diagnostics, Therapeutics, Nutraceuticals, Biologics
ProductVeterinary Drugs, Pet Food, Animal Supplements, Medical Devices, Wearable Devices
ServicesVeterinary Clinics, Pet Grooming, Pet Boarding, Pet Training, Pet Insurance
TechnologyDigital Health, Telemedicine, Wearable Technology, Genomics, Biotechnology, Artificial Intelligence
ComponentSoftware, Hardware, Services
ApplicationDisease Treatment, Preventive Care, Nutrition Management, Rehabilitation
DeviceMonitoring Devices, Therapeutic Devices, Diagnostic Devices
End UserVeterinary Hospitals, Home Care Settings, Research Institutes
SolutionsClinical Solutions, Operational Solutions, Financial Solutions
ModeIn-Person, Remote Monitoring, Telehealth

The Companion Animal Health Market is witnessing a dynamic shift in market share, pricing strategies, and product innovation. Leading companies are strategically launching new products to meet the growing demand for advanced animal healthcare solutions. The market is characterized by a diverse range of offerings that address various health needs, from preventive care to complex treatments. Pricing strategies are evolving in response to competitive pressures and consumer expectations, with a focus on delivering value through enhanced efficacy and customer satisfaction. In terms of competition benchmarking, prominent players are intensifying their efforts to differentiate through innovation and strategic partnerships. Regulatory influences play a pivotal role, with stringent guidelines shaping product development and market entry strategies. The market is also influenced by the increasing emphasis on animal welfare and the rising prevalence of zoonotic diseases. The competitive landscape is marked by the presence of multinational corporations and emerging regional players, each vying for a stronger foothold through technological advancements and expanded distribution networks.

Geographical Overview:

The Companion Animal Health Market is thriving across diverse regions, each showcasing unique growth dynamics. North America leads, driven by high pet ownership rates and advanced veterinary services. The region's focus on innovative healthcare solutions and preventive care enhances market growth. Europe follows, with a strong emphasis on pet welfare and regulatory frameworks supporting veterinary advancements. Increased spending on pet healthcare in this region further propels market expansion. In Asia Pacific, rapid urbanization and a growing middle class contribute to significant market growth. Rising pet adoption rates and increased awareness of animal health fuel demand for veterinary services. Emerging markets in Latin America and the Middle East & Africa present lucrative opportunities. In Latin America, economic development and rising disposable incomes drive the market. Meanwhile, the Middle East & Africa witness increasing investments in veterinary infrastructure, recognizing the importance of companion animal health in enhancing quality of life and economic growth.

Global tariffs and geopolitical tensions are significantly influencing the Companion Animal Health Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are navigating these challenges by enhancing domestic production capabilities and fostering innovation in veterinary pharmaceuticals and diagnostics. China's strategy is pivoting towards self-reliance, with increased investment in local manufacturing and research, while Taiwan leverages its robust biotech sector, although it remains vulnerable to cross-strait tensions. The global parent market is witnessing steady growth driven by rising pet ownership and advanced veterinary care. By 2035, the market is expected to thrive on technological advancements and strategic regional collaborations. Middle East conflicts could disrupt global supply chains and inflate energy prices, indirectly impacting production costs and market dynamics.

Key Trends and Drivers:

The Companion Animal Health Market is experiencing robust growth, propelled by rising pet ownership and increasing awareness of animal welfare. A significant trend is the surge in demand for advanced veterinary diagnostics and therapeutics, reflecting an emphasis on preventive care and early disease detection. Technological advancements, such as telemedicine and wearable health monitoring devices for pets, are transforming the landscape, offering convenience and improved health outcomes. Another key driver is the humanization of pets, with owners willing to invest in premium products and services. This trend is fostering innovation in areas like pet nutrition and personalized medicine. The expansion of veterinary clinics and pet healthcare infrastructure, particularly in emerging markets, is also contributing to market growth. Moreover, strategic partnerships and collaborations among industry players are facilitating the development of novel solutions and expanding market reach. Opportunities abound in the development of cost-effective treatments and diagnostic tools, particularly in regions with limited access to advanced veterinary care. Companies focusing on research and development to address specific health issues in companion animals are well-positioned to capitalize on these trends. The emphasis on sustainable and eco-friendly products is further shaping the market, aligning with broader consumer preferences for environmentally responsible choices.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Solutions
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Vaccines
    • 4.1.2 Pharmaceuticals
    • 4.1.3 Feed Additives
    • 4.1.4 Diagnostics
    • 4.1.5 Therapeutics
    • 4.1.6 Nutraceuticals
    • 4.1.7 Biologics
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Veterinary Drugs
    • 4.2.2 Pet Food
    • 4.2.3 Animal Supplements
    • 4.2.4 Medical Devices
    • 4.2.5 Wearable Devices
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Veterinary Clinics
    • 4.3.2 Pet Grooming
    • 4.3.3 Pet Boarding
    • 4.3.4 Pet Training
    • 4.3.5 Pet Insurance
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Digital Health
    • 4.4.2 Telemedicine
    • 4.4.3 Wearable Technology
    • 4.4.4 Genomics
    • 4.4.5 Biotechnology
    • 4.4.6 Artificial Intelligence
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software
    • 4.5.2 Hardware
    • 4.5.3 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Disease Treatment
    • 4.6.2 Preventive Care
    • 4.6.3 Nutrition Management
    • 4.6.4 Rehabilitation
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Monitoring Devices
    • 4.7.2 Therapeutic Devices
    • 4.7.3 Diagnostic Devices
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Veterinary Hospitals
    • 4.8.2 Home Care Settings
    • 4.8.3 Research Institutes
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Clinical Solutions
    • 4.9.2 Operational Solutions
    • 4.9.3 Financial Solutions
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 In-Person
    • 4.10.2 Remote Monitoring
    • 4.10.3 Telehealth

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Device
      • 5.2.1.8 End User
      • 5.2.1.9 Solutions
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Device
      • 5.2.2.8 End User
      • 5.2.2.9 Solutions
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Device
      • 5.2.3.8 End User
      • 5.2.3.9 Solutions
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Device
      • 5.3.1.8 End User
      • 5.3.1.9 Solutions
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Device
      • 5.3.2.8 End User
      • 5.3.2.9 Solutions
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Device
      • 5.3.3.8 End User
      • 5.3.3.9 Solutions
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Device
      • 5.4.1.8 End User
      • 5.4.1.9 Solutions
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Device
      • 5.4.2.8 End User
      • 5.4.2.9 Solutions
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Device
      • 5.4.3.8 End User
      • 5.4.3.9 Solutions
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Device
      • 5.4.4.8 End User
      • 5.4.4.9 Solutions
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Device
      • 5.4.5.8 End User
      • 5.4.5.9 Solutions
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Device
      • 5.4.6.8 End User
      • 5.4.6.9 Solutions
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Device
      • 5.4.7.8 End User
      • 5.4.7.9 Solutions
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Device
      • 5.5.1.8 End User
      • 5.5.1.9 Solutions
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Device
      • 5.5.2.8 End User
      • 5.5.2.9 Solutions
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Device
      • 5.5.3.8 End User
      • 5.5.3.9 Solutions
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Device
      • 5.5.4.8 End User
      • 5.5.4.9 Solutions
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Device
      • 5.5.5.8 End User
      • 5.5.5.9 Solutions
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Device
      • 5.5.6.8 End User
      • 5.5.6.9 Solutions
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Device
      • 5.6.1.8 End User
      • 5.6.1.9 Solutions
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Device
      • 5.6.2.8 End User
      • 5.6.2.9 Solutions
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Device
      • 5.6.3.8 End User
      • 5.6.3.9 Solutions
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Device
      • 5.6.4.8 End User
      • 5.6.4.9 Solutions
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Device
      • 5.6.5.8 End User
      • 5.6.5.9 Solutions
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Vetoquinol
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Dechra Pharmaceuticals
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Virbac
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Heska Corporation
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Zoetis
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Elanco Animal Health
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Boehringer Ingelheim Animal Health
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Ceva Sante Animale
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Phibro Animal Health
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 IDEXX Laboratories
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Merck Animal Health
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Bimeda
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Neogen Corporation
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Kyoritsu Seiyaku
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Ourofino Saude Animal
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Bio Chek
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Vetcare
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Norbrook Laboratories
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Hipra
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Eco Animal Health
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us